Covid
Cognitive Impairment in Post-COVID-19 Condition
Cognitive Impairment in Post-COVID-19 Condition

Prolonged cognitive dysfunction emerges as a common post-COVID-19 sequelae, warranting attention and management.

May 2024

Long-Term Symptoms Post-COVID-19
Long-Term Symptoms Post-COVID-19

Comparative analysis of long-term symptom profiles following COVID-19 versus other acute respiratory infections.

May 2024

Communicating Misinformation About COVID-19 on Soc
Communicating Misinformation About COVID-19 on Social Media

Ethical and legal guidelines are deemed necessary to limit the spread of misinformation about COVID-19 on social media platforms, emphasizing the importance of accurate and reliable information dissemination during public health crises.

May 2024

COVID-19: Effectiveness of Non-Pharmaceutical Inte
COVID-19: Effectiveness of Non-Pharmaceutical Interventions Examined

Effective implementation of non-pharmaceutical interventions buys time to enable the development and manufacturing of drugs and vaccines, highlighting the importance of public health measures in controlling the spread of COVID-19.

May 2024

Inhaled Fluticasone Furoate for Covid-19 Treatment
Inhaled Fluticasone Furoate for Covid-19 Treatment

Clinical efficacy of inhaled fluticasone furoate for treating Covid-19 is not demonstrated in study results, suggesting limited benefit in this context.

May 2024

COVID: WHO Classifies Variant EG.5 as of Interest
COVID: WHO Classifies Variant EG.5 as of Interest and Cases Resurface

The World Health Organization (WHO) classifies variant EG.5 of COVID-19 as of interest and urges countries to continue reporting cases, particularly amid a spike in cases during the summer in Europe and the US.

May 2024

Incidence of Diabetes Before and During the Pandem
Incidence of Diabetes Before and During the Pandemic

The incidence of new-onset diabetes during the COVID-19 pandemic is examined, highlighting potential factors contributing to its increased prevalence among young people.

April 2024

WHO Warns of ’Worrying Trends’ in COVID-19 Cas
WHO Warns of ’Worrying Trends’ in COVID-19 Cases

The WHO has raised concerns about increasing COVID-19 cases and urged booster vaccinations to mitigate potential worsening, especially with the onset of cold weather.

April 2024

COVID: What You Need to Know About EG.5
COVID: What You Need to Know About EG.5

Based on current data, the World Health Organization (WHO) classifies the risk of antibody escape from the EG.5 variant of COVID-19 as moderate, highlighting the importance of continued surveillance and response efforts.

April 2024

Notable Increase in Type 1 Diabetes with the COVID
Notable Increase in Type 1 Diabetes with the COVID-19 Pandemic

As COVID-19 cases increased, so did cases of type 1 diabetes, though the reasons behind this trend remain unclear. This article highlights the need for further research to understand the relationship between the pandemic and diabetes incidence.

April 2024

Allergies Artificial Intelligence Cancer Cardiovascular Child care Covid Diabetes Drugs Exercising Food & Health Hypertension Microbiology Neurology Obstetrics Ophtalmology Oral health Respiratory Skin care Sleep Smoking Surgery Vaccines Women's health
Top reads...
Reevaluating Sunlight Exposure New Study Unveils Effective TB Prevention Strategy Smoking, Alcohol Consumption, and Risk of Incident Diverticulitis Rotator cuff surgery Differences in the Top 20 Causes of Illness Between Men and Women